Categories : Oncology
Product Packaging : Single Vial
Product Composition : 3750 IU/5ml
PEG L-Asparaginase Injection is a specialized pegylated enzyme-based anticancer injectable formulation used primarily in the treatment of acute lymphoblastic leukemia (ALL). It works by depleting asparagine, an amino acid essential for the survival of certain cancer cells, thereby inhibiting protein synthesis and inducing cancer cell death.
The pegylated formulation (PEGylation) enhances the drug’s half-life, reduces immunogenicity, and allows for less frequent dosing with sustained therapeutic effect, making it a preferred option in modern oncology protocols.
Manufactured under stringent sterile and biotechnology-grade conditions, PEG L-Asparaginase Injection offered by Genliva Wellness LLP ensures high purity, stability, and consistent efficacy. As a trusted PEG L-Asparaginase Injection contract manufacturer and exporter from India, Genliva Wellness LLP provides oncology-focused biologic manufacturing, private label solutions, and global bulk supply.
Send MessagePEG L-Asparaginase Injection is a specialized pegylated enzyme-based anticancer injectable formulation used primarily in the treatment of acute lymphoblastic leukemia (ALL). It works by depleting asparagine, an amino acid essential for the survival of certain cancer cells, thereby inhibiting protein synthesis and inducing cancer cell death.
The pegylated formulation (PEGylation) enhances the drug’s half-life, reduces immunogenicity, and allows for less frequent dosing with sustained therapeutic effect, making it a preferred option in modern oncology protocols.
Manufactured under stringent sterile and biotechnology-grade conditions, PEG L-Asparaginase Injection offered by Genliva Wellness LLP ensures high purity, stability, and consistent efficacy. As a trusted PEG L-Asparaginase Injection contract manufacturer and exporter from India, Genliva Wellness LLP provides oncology-focused biologic manufacturing, private label solutions, and global bulk supply.
PEG L-Asparaginase Injection is commonly used in the treatment of:
This enzyme-based anticancer injection is administered under strict medical supervision in oncology and hematology settings.
Injectable dosage form offers critical advantages:
